DOCSLIB.ORG

Using Crispr-Cas9 Genome-Edited

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Using Crispr-Cas9 Genome-Edited Creating CRISPR-Cas9 genome edited iPSC lines to model a patient-specific mutation in mitochondrial disease Nelli Jalkanen Master’s Thesis Master’s Degree Programme in Translational Medicine Faculty of Medicine University of Helsinki 2020 Abstract Tiedekunta – Fakultet – Faculty Koulutusohjelma – Utbildingsprogram – Degree Programme Faculty of Medicine Translational Medicine MSc. Tekijä – Författare – Author Nelli Jalkanen Työn nimi – Arbetets titel – Title Creating CRISPR-Cas9 genome edited iPSC lines to model a patient-specific mutation in mitochondrial disease Oppiaine/Opintosuunta – Läroämne/Studieinriktning – Subject/Study track Translational Medicine, specialisation in Neuroscience and Psychobiology Työn laji – Arbetets art – Level Aika – Datum – Month and year Sivumäärä – Sidoantal – Number of pages Master’s thesis October 2020 74 Tiivistelmä – Referat – Abstract Mitochondrial aminoacyl tRNA-synthetases (mt-aaRS) catalyse the charging of tRNAs with their cognate amino acids in mitochondria. Mutations in mt-aaRS cause tissue-specific mitochondrial diseases, especially affecting tissues with high energy expenditure like the nervous system, heart, and kidneys. However, disease mechanisms for the heterogeneous group of diseases have not yet been fully elucidated. Harnessing CRISPR-Cas9 genome editing in induced pluripotent stem cells (iPSC) provides an opportunity to model mt-aaRS mutations in vitro and investigate the effects of individual mutations on cellular phenotype. SARS2 encodes mitochondrial seryl tRNA-synthetase, and its c.1347 G>A mutation causes severe childhood-onset progressive spastic paresis. Here, CRISPR-Cas9 ribonucleoprotein (RNP) complex and associated donor template were used to induce homology directed repair (HDR) the genome of iPSC and knock-in the patient mutation. Guide RNAs were designed and tested for efficiency before electroporation into wild type iPSC. Clonal cell lines were made by low-density seeding and manual colony picking. The expression of pluripotency markers was measured by RT-qPCR. RT-qPCR and Western blot measured SARS2 mRNA expression and protein level respectively. The success and precision of genome editing were analysed by Sanger sequencing, comparing the performance of the different guide RNAs, and screening regions of potential off-target genome editing. Two genome-edited iPSC lines with the SARS2 c.1347 G>A mutation were successfully generated to model the patient mutation. The iPSC lines expressed pluripotency markers and contained no off-target genome editing and modelled the patient’s decrease in SARS2 protein level and mRNA expression. More evidence of differentiation ability is needed before differentiation into the affected cell type (motor neurons) and further disease modelling. The efficiency of CRISPR-Cas9 for genome editing, especially harnessing HDR in iPSC, is an area of future research. Avainsanat – Nyckelord – Keywords CRISPR-Cas9, genome editing, iPSC, disease modelling, mitochondrial aminoacyl tRNA-synthetase, seryl tRNA-synthetase, mitochondrial disease Ohjaaja tai ohjaajat – Handledare – Supervisor or supervisors Henna Tyynismaa PhD, Associate Professor Tiina Rasila PhD Säilytyspaikka – Förvaringställe – Where deposited Helsingin yliopiston kirjasto, Helsingfors universitets bibliotek, Helsinki University Library Muita tietoja – Övriga uppgifter – Additional information 1 Table of Contents Abstract ........................................................................................................................................... 1 Abbreviations .................................................................................................................................. 4 1. Introduction ................................................................................................................................. 7 1.1 Mitochondria ............................................................................................................................. 7 1.2 Mitochondrial tRNA-synthetases (mt-aaRS) in health and mitochondrial disease ................... 8 1.3 Mitochondrial seryl-tRNA synthetase..................................................................................... 12 1.4 SARS2 patient genetics and clinical phenotype ....................................................................... 13 1.5 Induced pluripotent stem cells in disease modelling ............................................................... 14 1.6 The creation and significance of isogenic control clonal cell lines ......................................... 16 1.7 CRISPR-Cas ........................................................................................................................... 16 1.7.1 Origins of CRISPR-Cas and developments in research ....................................................... 16 1.7.2 The CRISPR-Cas immunity mechanism and types of CRISPR-Cas ................................... 17 1.7.3 CRISPR-Cas9 in genome editing and disease modelling .................................................... 20 1.8 Aims ........................................................................................................................................ 24 2. Materials & Methods ................................................................................................................ 25 2.1 Cell culture ........................................................................................................................ 25 2.1.1 HEK293 cells ................................................................................................................ 25 2.1.2 iPSC .............................................................................................................................. 25 2.1.3 Fibroblasts ......................................................................................................................... 25 2.2 crRNA design .......................................................................................................................... 26 2.3 gRNA production .................................................................................................................... 28 2.4 gRNA testing in HEK293 cells ............................................................................................... 30 2.5 T7 endonuclease assay ............................................................................................................ 31 2.6 ssODN repair template design ................................................................................................ 32 2.7 Creating the genome edited iPSC lines ................................................................................... 33 2.7.1 Electroporation .............................................................................................................. 33 2.7.2 Subcloning .................................................................................................................... 34 2.7.3 Colony picking .............................................................................................................. 35 2.7.4 Cryopreservation of clonal cell lines............................................................................. 35 2.7.5 Thawing ........................................................................................................................ 35 2.8 Sanger sequencing............................................................................................................. 36 2.9 TOPO-Cloning .................................................................................................................. 37 2.10 Analysis and sequencing of off-target genome editing ..................................................... 38 2.11 Analyses of HDR efficiency ................................................................................................. 38 2.12 Cell collection for RT-qPCR and Western blotting .......................................................... 39 2 2.13 RT-qPCR ........................................................................................................................... 39 2.14 Western blot ...................................................................................................................... 40 2.14.1 Protein extraction .......................................................................................................... 40 2.14.2 SDS-PAGE electrophoresis and blotting ...................................................................... 40 3. Results ................................................................................................................................... 42 3.1 Two out of four crRNA were chosen for iPSC electroporation based on gene modification efficiency in HEK293 cells ........................................................................................................... 43 3.2 iPSC electroporation ............................................................................................................... 45 3.2.1 Gene modification efficiencies in the electroporated cell populations ................................ 45 3.2.2 ssODN integration and HDR efficiency in the electroporated pools ................................... 46 3.3 Clonal cell line creation .......................................................................................................... 48 3.3.1 Rates of NHEJ and HDR in the clonal cell lines ................................................................. 48 3.3.2 Two SARS2
Load more

Recommended publications
  • Computational and Experimental Approaches for Evaluating the Genetic Basis of Mitochondrial Disorders
    Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Lieber, Daniel Solomon. 2013. Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders. Doctoral dissertation, Harvard University. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11158264 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders A dissertation presented by Daniel Solomon Lieber to The Committee on Higher Degrees in Systems Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Systems Biology Harvard University Cambridge, Massachusetts April 2013 © 2013 - Daniel Solomon Lieber All rights reserved. Dissertation Adviser: Professor Vamsi K. Mootha Daniel Solomon Lieber Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders Abstract Mitochondria are responsible for some of the cell’s most fundamental biological pathways and metabolic processes, including aerobic ATP production by the mitochondrial respiratory chain. In humans, mitochondrial dysfunction can lead to severe disorders of energy metabolism, which are collectively referred to as mitochondrial disorders and affect approximately 1:5,000 individuals. These disorders are clinically heterogeneous and can affect multiple organ systems, often within a single individual. Symptoms can include myopathy, exercise intolerance, hearing loss, blindness, stroke, seizures, diabetes, and GI dysmotility.
    [Show full text]
  • Plos Biology
    PLOS BIOLOGY RESEARCH ARTICLE A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 Yadi Zhou1☯, Yuan Hou1☯, Jiayu Shen1, Reena Mehra2,3, Asha Kallianpur1,2, Daniel A. Culver4,5, Michaela U. Gack6, Samar Farha4,5, Joe Zein2,4, Suzy Comhair2,4, 2,4 2,4 2,4 1,2,4,7,8 Claudio Fiocchi , Thaddeus StappenbeckID , Timothy Chan , Charis EngID , Jae 2,4 2,3 2,4 1,2,8 a1111111111 U. Jung , Lara JehiID , Serpil Erzurum , Feixiong ChengID * a1111111111 a1111111111 1 Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, 2 Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western a1111111111 Reserve University, Cleveland, Ohio, United States of America, 3 Neurological Institute, Cleveland Clinic, a1111111111 Cleveland, Ohio, United States of America, 4 Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, 5 Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, 6 Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, Florida, United States of America, 7 Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America, 8 Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, OPEN ACCESS United States of America Citation: Zhou Y, Hou Y, Shen J, Mehra R, Kallianpur A, Culver DA, et al. (2020) A network ☯ These authors contributed equally to this work. * [email protected] medicine approach to investigation and population- based validation of disease manifestations and drug repurposing for COVID-19.
    [Show full text]
  • Comparative Host-Coronavirus Protein Interaction Networks Reveal Pan
    Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms David Gordon, Joseph Hiatt, Mehdi Bouhaddou, Veronica Rezelj, Svenja Ulferts, Hannes Braberg, Alexander Jureka, Kirsten Obernier, Jeffrey Guo, Jyoti Batra, et al. To cite this version: David Gordon, Joseph Hiatt, Mehdi Bouhaddou, Veronica Rezelj, Svenja Ulferts, et al.. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science, American Association for the Advancement of Science, 2020, 370 (6521), pp.eabe9403. 10.1126/science.abe9403. hal-03102291 HAL Id: hal-03102291 https://hal.archives-ouvertes.fr/hal-03102291 Submitted on 7 Jan 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Corrected 21 December 2020. See full text. RESEARCH ◥ RESULTS: Quantitative comparison of the 389 RESEARCH ARTICLE SUMMARY interactors of SARS-CoV-2, 366 of SARS-CoV-1, and 296 of MERS-CoV highlighted interactions CORONAVIRUS with host processes that are conserved across all three viruses, including where nonortholo- Comparative host-coronavirus protein interaction gous proteins from different virus strains seem to fill similar roles. We also localized each networks reveal pan-viral disease mechanisms individually-expressed viral protein by micros- copy and then raised and validated antisera David E.
    [Show full text]
  • Next Generation Sequencing for SARS-Cov-2
    Next generation sequencing for SARS-CoV-2 Next generation sequencing for SARS-CoV-2/COVID-19 Acknowledgements The PHG Foundation and FIND are grateful for the insight provided by the individuals consulted during the course of this work. Full consultee acknowledgements are listed in Appendix 1 Lead writers Chantal Babb de Villiers (PHG Foundation) Laura Blackburn (PHG Foundation) Sarah Cook (PHG Foundation) Joanna Janus (PHG Foundation) Emma Johnson (PHG Foundation) Mark Kroese (PHG Foundation) Concept development and lead review Swapna Uplekar (FIND) Reviewers Devy Emperador (FIND) Jilian Sacks (FIND) Marva Seifert (FIND) Anita Suresh (FIND) Report production PHG Foundation July 2020; Update March 2021 This report is the result of PHG Foundation’s independent research and analysis and is not linked to a third party in any way. PHG Foundation has provided occasional analytical services to Oxford Nanopore Technologies (ONT) as part of a consultancy agreement. Next generation sequencing for SARS-CoV-2 2 Contents Introduction 6 1.1 Methods 6 1.2 SARS-CoV-2 7 1.3 SARS-CoV-2 genome sequencing 8 1.4 SARS-CoV-2 biology 9 2 Global surveillance: applications of sequencing technologies and techniques 14 2.1 Overview of surveillance 15 2.2 Overview of genomic surveillance 17 2.3 Sequencing initiatives across the globe 18 2.4 Sequencing data repositories and data sharing 25 2.5 SARS-CoV-2 genomic data releases by country 26 2.6 Additional sequencing related initiatives 29 3 Diagnostics and the role of sequencing 32 3.1 Sequencing for diagnosis 32 3.2
    [Show full text]
  • Variation in Protein Coding Genes Identifies Information Flow
    bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 1 1 2 3 4 5 Variation in protein coding genes identifies information flow as a contributor to 6 animal complexity 7 8 Jack Dean, Daniela Lopes Cardoso and Colin Sharpe* 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Institute of Biological and Biomedical Sciences 25 School of Biological Science 26 University of Portsmouth, 27 Portsmouth, UK 28 PO16 7YH 29 30 * Author for correspondence 31 [email protected] 32 33 Orcid numbers: 34 DLC: 0000-0003-2683-1745 35 CS: 0000-0002-5022-0840 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Abstract bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 2 1 Across the metazoans there is a trend towards greater organismal complexity. How 2 complexity is generated, however, is uncertain. Since C.elegans and humans have 3 approximately the same number of genes, the explanation will depend on how genes are 4 used, rather than their absolute number.
    [Show full text]
  • Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder Technical Brief Number 23
    Technical Brief Number 23 Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder Technical Brief Number 23 Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2012-00011-I Prepared by: ECRI Institute–Penn Medicine Evidence-based Practice Center Plymouth Meeting, PA Investigators: Fang Sun, M.D., Ph.D. Jeff Oristaglio, Ph.D. Susan E. Levy, M.D., M.P.H. Hakon Hakonarson, M.D., Ph.D. Nancy Sullivan, B.A. Joann Fontanarosa, Ph.D. Karen M. Schoelles, M.D., M.S., FACP AHRQ Publication No. 15-EHC024-EF June 2015 This report is based on research conducted by the ECRI–Penn Medicine AHRQ Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (290-2012-00011-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment.
    [Show full text]
  • Repetitive DNA: a Tool to Explore Animal Genomes/Transcriptomes
    Chapter 8 Repetitive DNA: A Tool to Explore Animal Genomes/Transcriptomes Deepali Pathak and Sher Ali Additional information is available at the end of the chapter http://dx.doi.org/10.5772/48259 1. Introduction The analysis of genetic diversity and relatedness within and between the different species and populations has been a major theme of research for many biologists. With the availability of whole-genome sequencing for an increasing number of species, focus has been shifted to the development of molecular markers based on DNA or protein polymorphism. DNA sequences originate and undergo evolutionary metamorphoses’ and thus may be used as powerful genetic markers to characterize genomes of wide range of species. This type of analysis is called fingerprinting, profiling or genotyping. DNA profiling based on typing individuals using highly variable minisatellites in the human genome was first developed by Jeffreys et al (1985). He demonstrated short repeat sequences tandemly arranged within the gene(s) and each organism has a unique pattern of the arrangement of these minisatellites, the only exception being multiple individuals from a single zygote (e.g. identical twins). DNA fingerprinting technique was notably used to help solve crimes and determine paternity. In addition, with the advances in Molecular biology techniques, isolation of genes tagged with minisatellites has become the most powerful tool for genome analysis. The term “repetitive sequences” (repeats, DNA repeats, repetitive DNA) refers to DNA fragments that are present in multiple copies in the genome. These sequences exhibit a high degree of polymorphism due to variation in the number of their repeat units caused by mutations involving several mechanisms (Tautz, 1989).
    [Show full text]
  • Computational and Experimental Approaches for Evaluating the Genetic Basis of Mitochondrial Disorders
    Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Lieber, Daniel Solomon. 2013. Computational and Experimental Citation Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders. Doctoral dissertation, Harvard University. Accessed April 17, 2018 4:10:16 PM EDT Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11158264 This article was downloaded from Harvard University's DASH Terms of Use repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA (Article begins on next page) Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders A dissertation presented by Daniel Solomon Lieber to The Committee on Higher Degrees in Systems Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Systems Biology Harvard University Cambridge, Massachusetts April 2013 © 2013 - Daniel Solomon Lieber All rights reserved. Dissertation Adviser: Professor Vamsi K. Mootha Daniel Solomon Lieber Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders Abstract Mitochondria are responsible for some of the cell’s most fundamental biological pathways and metabolic processes, including aerobic ATP production by the mitochondrial respiratory chain. In humans, mitochondrial dysfunction can lead to severe disorders of energy metabolism, which are collectively referred to as mitochondrial disorders and affect approximately 1:5,000 individuals. These disorders are clinically heterogeneous and can affect multiple organ systems, often within a single individual.
    [Show full text]
  • A Unified Framework of Overlapping Genes
    Genomics 100 (2012) 231–239 Contents lists available at SciVerse ScienceDirect Genomics journal homepage: www.elsevier.com/locate/ygeno A unified framework of overlapping genes: Towards the origination and endogenic regulation Meng-Ru Ho a, Kuo-Wang Tsai b, Wen-chang Lin c,⁎ a Biodiversity Research Center, Academia Sinica, Taipei 115, Taiwan b Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan c Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan article info abstract Article history: Overlapping genes are pairs of adjacent genes whose genomic regions partially overlap. They are notable by Received 27 January 2012 their potential intricate regulation, such as cis-regulation of nested gene-promoter configurations, and Accepted 25 June 2012 post-transcriptional regulation of natural antisense transcripts. The originations and consequent detailed reg- Available online 2 July 2012 ulation remain obscure. Herein, we propose a unified framework comprising biological classification rules followed by extensive analyses, namely, exon-sharing analysis, a human–mouse conservation study, and Keywords: transcriptome analysis of hundreds of microarrays and transcriptome sequencing data (mRNA-Seq). We Overlapping gene Natural antisense transcript (NAT) demonstrate that the tail-to-tail architecture would result from sharing functional elements in Gene regulation 3′-untranslated regions (3′-UTRs) of pre-existing genes. Dissimilarly, we illustrate that the other gene over- Cis-regulatory element laps would originate from a new gene arising in a pre-existing gene locus. Interestingly, these types of Promoter coupled overlapping genes may influence each other synergistically or competitively during transcription, Local chromatin status depending on the promoter configurations. This framework discloses distinctive characteristics of over- lapping genes to be a foundation for a further comprehensive understanding of them.
    [Show full text]
  • Human Identical Sequences of SARS-Cov-2 Promote Clinical Progression of COVID-19 by Upregulating Hyaluronan Via Namirna-Enhancer Network
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.04.361576; this version posted November 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Human Identical Sequences of SARS-CoV-2 Promote Clinical Progression of COVID-19 by Upregulating Hyaluronan via NamiRNA-Enhancer Network Wei Li1,†, Shuai Yang1,†, Peng Xu1,†, Dapeng Zhang2,†, Ying Tong1,†, Lu Chen1, Ben Jia1, Ang Li3, Daoping Ru1, Baolong Zhang1, Mengxing Liu1, Cheng Lian1, Cancan Chen1, Weihui Fu3, Songhua Yuan3, Xiaoguang Ren1, Ying Liang1, Zhicong Yang1, Wenxuan Li1, Shaoxuan Wang1, Xiaoyan Zhang3, Hongzhou Lu4, Jianqing Xu3,*, Hailing Wang2,*, Wenqiang Yu1,* Affiliations 1 Shanghai Public Health Clinical Center and Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China. 2 State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China. 3 Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China 4 Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. † These authors contributed equally. *Correspondence: [email protected] (JQ.X.), [email protected]
    [Show full text]
  • Sample Thesis Template
    Molecular and Genetic Basis of Inherited Optic Neuropathies Padraig James Flannery BA MSc Thesis submitted to Newcastle University in candidature for the degree of Doctor of Philosophy Institute of Genetic Medicine Faculty of Medical Sciences Newcastle University To Mum, Dad and Ciara i Abstract Inherited optic neuropathies represent an important cause of chronic visual morbidity among children and young adults. This group of disorders is genetically heterogeneous and it can be caused by pathogenic mutations within both the mitochondrial and nuclear genomes. The unifying pathophysiological theme is mitochondrial dysfunction, but the specific disease mechanisms that ultimately precipitate neuronal loss, particularly retinal ganglion cell (RGC) degeneration, still remain unclear. The work presented in this thesis provides further insight into the molecular and genetic basis of two classical forms of inherited optic neuropathy, namely autosomal dominant optic atrophy (DOA) and Wolfram syndrome. Dominant optic atrophy (DOA) secondary to pathogenic OPA1 mutations is the most common inherited optic neuropathy diagnosed in clinical practice. The pathology is characterised by the preferential loss of RGCs within the inner retina and optic nerve degeneration. Although most OPA1 mutation carriers will only develop isolated optic atrophy, a subgroup of patients, referred to as DOA plus (DOA+), will develop more severe neuromuscular complications in addition to visual failure. The complexity of these clinical presentations may be due in part, to
    [Show full text]
  • Characterization of Rare ABCC8 Variants Identified in Spanish
    www.nature.com/scientificreports OPEN Characterization of rare ABCC8 variants identifed in Spanish pulmonary arterial hypertension patients Mauro Lago‑Docampo 1,2, Jair Tenorio 3,4,5, Ignacio Hernández‑González 6,7,8, Carmen Pérez‑Olivares7,8,9, Pilar Escribano‑Subías 7,8,9, Guillermo Pousada 2, Adolfo Baloira10, Miguel Arenas 1,2, Pablo Lapunzina 3,4,5 & Diana Valverde 1,2* Pulmonary Arterial Hypertension (PAH) is a rare and fatal disease where knowledge about its genetic basis continues to increase. In this study, we used targeted panel sequencing in a cohort of 624 adult and pediatric patients from the Spanish PAH registry. We identifed 11 rare variants in the ATP‑binding Cassette subfamily C member 8 (ABCC8) gene, most of them with splicing alteration predictions. One patient also carried another variant in SMAD1 gene (c.27delinsGTA AAG ). We performed an ABCC8 in vitro biochemical analyses using hybrid minigenes to confrm the correct mRNA processing of 3 missense variants (c.211C > T p.His71Tyr, c.298G > A p.Glu100Lys and c.1429G > A p.Val477Met) and the skipping of exon 27 in the novel splicing variant c.3394G > A. Finally, we used structural protein information to further assess the pathogenicity of the variants. The results showed 11 novel changes in ABCC8 and 1 in SMAD1 present in PAH patients. After in silico and in vitro biochemical analyses, we classifed 2 as pathogenic (c.3288_3289del and c.3394G > A), 6 as likely pathogenic (c.211C > T, c.1429G > A, c.1643C > T, c.2422C > A, c.2694 + 1G > A, c.3976G > A and SMAD1 c.27delinsGTA AAG ) and 3 as Variants of Uncertain Signifcance (c.298G > A, c.2176G > A and c.3238G > A).
    [Show full text]